ArticleFrontiers in pharmacology2026

Preclinical evaluation of CPL423: a novel potent small-molecule inhibitor of TAM family and FLT3 kinase for cancer therapy.

Agata Mikołajczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.